Publishing WHO R&D Roadmaps
- Funded by Wellcome Trust
- Total publications:2 publications
Grant number: 220522
Grant search
Key facts
Disease
Lassa Haemorrhagic Fever, Ebola…Start & end year
20202020Known Financial Commitments (USD)
$59,280Funder
Wellcome TrustPrincipal Investigator
Dr. Marie-Pierre PreziosiResearch Location
SwitzerlandLead Research Institution
World Health Organization, SwitzerlandResearch Priority Alignment
N/A
Research Category
Policies for public health, disease control & community resilience
Research Subcategory
Communication
Special Interest Tags
N/A
Study Type
Not applicable
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Background Information: The research and development (R&D) Blueprint is a global strategy and preparedness plan to address highly infectious diseases and strengthen the emergency response by bringing medical technologies to patients during epidemics. For each of these priority diseases, WHO is coordinating the elaboration of R&D roadmaps, to serve as collaborative frameworks underpinning strategic goals and research priority areas to accelerate the development of diagnostics, therapeutics and vaccines to prevent and control severe emerging diseases. R&D roadmaps have been developed for 4 priority diseases with epidemic potential: Crimean-Congo hemorrhagic fever and Ebola/Marburg virus diseases, Lassa Fever and Nipah virus disease. Key Goals: Effective publication and dissemination of these roadmaps, together with communication and advocacy, will help to achieve the R&D blueprint and roadmaps goals. How the funds will be used: To support the publishing costs of 4 of the Research and Development (R&D) Blueprint Roadmaps.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC